Mark Irving

Surefire Resources has commissioned METS Engineering to undertake vital metallurgical testwork at its Victory Bore project in Western Australia’s Mid West region to help further its bid to impact Australasia’s emerging vanadium battery sector. Management hopes the move will boost the project’s value by finding a streamlined separation process to extract vanadium from its magnetite hosts.

ASX-listed Estrella Resources has run the rule over a promising 5A nickel target at its Spargoville project, 20km south-west of Kambalda in WA’s Goldfields, and has opted for an underground decline operation over open-pit mining. The company will now press full-steam ahead towards restarting the historic mining at Spargoville of nickel – now a much-needed battery metal.

Venture Minerals is keen to get its drill bits spinning in search of rare earths elements in WA after adding two new Mid West projects to its portfolio and identifying two new targets at its existing Kulin deposit, south-east of Perth. The diversified minerals explorer has developed a strategy to expand its exposure in the rare earths space with a bias for clay-hosted mineralisation.

ASX-listed biotech Radiopharm Theranostics has secured the supply of a valuable isotope that will enable the company to soon kick off a human trial of a treatment designed to tackle brain cancer. Management says the isotope, Therbium-161, boasts great promise in helping to expand treatment options for patients living with cancer – but it is in short supply.

Buru Energy is forging ahead in its bid to unlock the massive potential of its Rafael 1 well, east of Broome in WA’s Canning Basin, by taking another important step on its pathway to production. Buru has lodged a declaration of location application with the State Government – a move described as a key step towards the commercialisation and monetisation of its gas and condensate resource.

A women’s hospital in India has delivered good news for reproductive biotechnology innovator Memphasys, reporting the first successful birth for the company’s “Felix” sperm separation system. Memphasys has also scored a separate win with its first commercial sales in another key market – Japan. India offers Memphasys a $50 million opportunity, while Japan is twice that size.

Zuleika Gold has its drills on standby after it uncovered encouraging gold anomalies in Menzies. The finds have provided a boost for its hopes of producing the precious yellow metal in the “medium term”. The company says one anomaly is 2km long and coincides with a line of poorly-tested historical workings. It plans to complete an in-field review, with possible in-fill geochemistry, prior to drilling.

Australians suffering hard-to-beat cancers are set to be the first to benefit from trials of new treatments conducted as part of a two-year partnership between Radiopharm Theranostics and GenesisCare. Tumours in the brain, lung and prostate will be targeted in three first-phase clinical trials in Australia, which will be aimed at studying the safety and tolerability of Radiopharm’s novel radiopharmaceutical treatments.

Allup Silica is rapidly ticking boxes at its Sparkler project in the South-West of WA as it readies the silica sands project for a mining licence which it will apply for next quarter. The company has appointed the South-West Aboriginal Land and Sea Council to undertake a Heritage Survey and it has also just wrapped up an auger drilling campaign at its Dune Buggy and Pink Bark projects near Esperance with some success.